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1. Introduction 
Calcium ions (Ca2+) are present in low concentrations in the cytosol (~100 nM) and in 
high concentrations (in mM range) in both the extracellular medium and intracellular 
stores (mainly sarco/endo/plasmic reticulum, SR). This differential allows the calcium ion 
to be a ubiquitous 2nd messenger that carries information essential for cellular functions 
as diverse as contraction, metabolism, apoptosis, proliferation and/or hypertrophic 
growth. The mechanisms responsible for generating a Ca2+ signal greatly differ from one 
cell type to another. In the different types of vascular smooth muscle cells (VSMC), 
enormous variations do exist with regard to the mechanisms responsible for generating 
Ca2+ signal. In each VSMC phenotype (synthetic/proliferating1 and contractile2 [1], tonic 
or phasic), the Ca2+ signaling system is adapted to its particular function and is due to 
the specific patterns of expression and regulation of Ca2+ handling molecules (Figure 1). 
For instance, in contractile VSMCs, the initiation of contractile events is driven by mem-
brane depolarization; and the principal entry-point for extracellular Ca2+ is the voltage-
operated L-type calcium channel (LTCC). In contrast, in synthetic/proliferating VSMCs, 
the principal way-in for extracellular Ca2+ is the store-operated calcium (SOC) channel. 
Whatever the cell type, the calcium signal consists of limited elevations of cytosolic free 
calcium ions in time and space. The calcium pump, sarco/endoplasmic reticulum Ca2+ 
ATPase (SERCA), has a critical role in determining the frequency of SR Ca2+ release by 
controlling the velocity of Ca2+ upload into the sarcoplasmic reticulum (SR) and the Ca2+ 
sensitivity of SR calcium channels, Ryanodin Receptor, RyR and Inositol tri-Phosphate 
                                                                 
1Synthetic VSMCs have a fibroblast appearance, proliferate readily, and synthesize increased levels of various 
extracellular matrix components, particularly fibronectin, collagen types I and III, and tropoelastin [1]. 
2Contractile VSMCs have a muscle-like or spindle-shaped appearance and well-developed contractile apparatus 
resulting from the expression and intracellular accumulation of thick and thin muscle filaments [1].  
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Receptor, IP3R. Therefore, it is a major player in determining the spacio-temporal pat-
terns of intracellular calcium signaling. This chapter focuses on the changes in Ca2+ sig-
naling associated with different VSMC phenotypes. We will discuss the physiological 
implications of altered expressions of Ca2+ channels and pumps (referred to as Ca2+ han-
dling proteins) and how they contribute to VSMC dysfunction in vascular disease.  
 
Figure 1. Schematic representation of Calcium Cycling in Contractile and Proliferating VSMCs. Left 
panel: schematic representation of calcium cycling in quiescent /contractile VSMCs. Contractile re-
sponse is initiated by extracellular Ca2+ influx due to activation of Receptor Operated Ca2+ channels 
(through phosphoinositol-coupled receptor) or to activation of L-Type Calcium channels (through an 
increase in luminal pressure). Small increase of cytosolic due IP3 binding to IP3R (puff) or RyR activa-
tion by LTCC or ROC-dependent Ca2+ influx leads to large SR Ca2+ release due to the activation of 
IP3R or RyR clusters (“Ca2+-induced Ca2+release” phenomenon). Cytosolic Ca2+ is rapidly reduced by 
SR calcium pumps (both SERCA2a and SERCA2b are expressed in quiescent VSMCs), maintaining 
high concentration of cytosolic Ca2+ and setting the sensitivity of RyR or IP3R for the next spike. 
Contraction of VSMCs occurs during oscillatory Ca2+ transient. Middle panel: schematic representa-
tion of atherosclerotic vessel wall. Contractile VSMC are located in the media layer, synthetic VSMC 
are located in sub-endothelial intima. Right panel: schematic representation of calcium cycling in 
quiescent /contractile VSMCs. Agonist binding to phosphoinositol-coupled receptor leads to the 
activation of IP3R resulting in large increase in cytosolic Ca2+. Calcium is weakly reduced by SR 
calcium pumps (only SERCA2b, having low turnover and low affinity to Ca2+ is expressed). Store 
depletion leads to translocation of SR Ca2+ sensor STIM1 towards PM, resulting in extracellular Ca2+ 
influx though opening of Store Operated Channel (CRAC). Resulted steady state Ca2+ transient is 
critical for activation of proliferation-related transcription factors ‘NFAT). Abbreviations: PLC - 
phospholipase C; PM - plasma membrane; PP2B - Ca2+/calmodulin-activated protein phosphatase 2B 
(calcineurin); ROC- receptor activated channel; IP3 - inositol-1,4,5-trisphosphate, IP3R - inositol-1,4,5-
trisphosphate receptor; RyR - ryanodine receptor; NFAT - nuclear factor of activated T-lymphocytes; 
VSMC - vascular smooth muscle cells; SERCA - sarco(endo)plasmic reticulum Ca2+ ATPase; SR - 
sarcoplasmic reticulum.  
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2. General aspects of calcium cycling and signaling in vascular smooth 
muscle cells  
Besides maintaining vascular tone in mature vessels, VSMCs also preserve blood vessel 
integrity [2]. In other words, VSMCs are also instrumental for vascular remodeling and 
repair associated with VSMCs proliferation and migration. Interestingly, Ca2+ plays a central 
role in both physiological processes. In VSMCs, calcium signaling involves a cross-
regulation of Ca2+ influx, sarcolemmal membrane signaling molecules and Ca2+ release and 
uptake from the sarco/endo/plasmic reticulum and mitochondria, which plays a central role 
in both vascular tone and integrity.  
2.1. Calcium handling by the plasma membrane’s calcium channels and pumps 
Membrane depolarization is believed to be a key process for the activation of calcium events 
in mature VSMCs. Thus, much attention has been given to uncovering the various mecha-
nisms responsible for triggering this depolarization. Increased intra-vascular pressure of 
resistance arteries stimulates gradual membrane depolarization in VSMCs, increasing the 
probability of opening L-type high voltage-gated Ca2+ channels (Cav1.2) (LTCC) [3, 4]. Al-
ternatively, the calcium-dependent contractile response can be induced through the activa-
tion of specific membrane receptors coupled to phospholipase C (PLC) isoforms3. The vari-
ous isoforms of transient receptor potential (TRP) ion channel family, particularly TRPC3, 
TRPC6 and TRPC7 possibly activated directly by diacyl glycerol (DAG), can also contribute 
to initial plasma membrane Ca2+ influx and subsequent membrane depolarization [5-8]. 
Non-selective receptor-activated canonical TRPC6 channel, that conduct large sodium (Na2+) 
currents was also suggested to contribute to membrane depolarization and subsequent L-
type channel activation [9, 10]. Membrane depolarization can spread to neighboring cells by 
current flow through gap junctions providing a synchronization mechanism for VSMC 
membrane depolarization within the vessel wall [11, 12].  
Among voltage-insensitive calcium influx pathways, the store-operated Ca2+ channels 
(SOC), maintain a long-term cellular Ca2+ signal. They are activated upon a decrease of 
internal store Ca2+ concentration resulting from a Ca2+ release via the opening of SR Ca2+ 
release channels. SOC was first hypothesized in 1986 [13], a paradigm that was confirmed 
by the identification of its two essential regulatory components, the SR/ER located Ca2+ 
sensor STIM1 (stromal interaction molecule) and the Ca2+ channels Orai1 [14-17]. Upon 
decrease of [Ca2+] in the reticulum (<500µM), Ca2+ dissociates from STIM1; then STIM1 
molecules oligomerize and translocate to specialized cortical reticulum compartments 
adjacent to the plasma membrane [18, 19]. There, the STIM1 cytosolic activating domains 
bind to and cluster the Orai proteins into an opened archaic Ca2+ channel known as Ca2+-
release activated Ca2+ channel (CRAC) 4. Furthermore, transient receptor potential ion 
                                                                 
3All isoforms of PLC, catalyze the hydrolysis of phosphatidylinositol4,5-biphosphate (PIP2) to produce the intracellular 
messengers IP3 increase and diacylglycerol (DAG); both of which promote cytosolic Ca2+ rise through activation of 
plasma membrane or sarcoplasmic reticulum calcium channels. 
4 The CRAC is responsible for the “2h cytosolic Ca2+
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channel (TRPC) family members have also been demonstrated to participate in SOC 
channels functioning via interactions with STIM1 and Orai proteins [20-22].  
The calcium signal is terminated by membrane hyper-polarization and cytosolic Ca2+ removal. 
First, calcium sparks resulting from the opening of sub-plasmalemmal clusters of RyR activate 
large-conductance Ca2+ sensitive K+ (BK) channels. Then, the resulting spontaneous transient 
outward currents (STOC) hyperpolarize the membrane and decrease the open probability of L-
type Ca2+ channels [23]. Cytosolic calcium is extruded at the level of plasma membrane by 
plasma membrane Ca2+ ATPase (PMCA) and the Na+/Ca2+ exchanger (NCX) [24, 25]. The 
principal amount of cytosolic Ca2+ (> 70%) is re-uploaded to the internal store.  
2.2. Calcium handling by the sarco/endoplasmic reticulum’s calcium channels 
and pumps 
The initial entry of Ca2+ through plasma membrane channels triggers large Ca2+ release from 
the internal store via the process of Ca2+-induced Ca2+-release (CICR). The mechanism 
responsible for initiating Ca2+ release depends on Ca2+ sensitive SR calcium channels, the 
ryanodin receptor (RyR)5 or the IP3 receptor (IP3R). Indeed, IP3R and RyR are highly 
sensitive to cytosolic Ca2+ concentrations and when cytosolic Ca2+ concentration ranges from 
nM to µM, they open up. On the contrary, a higher cytosolic Ca2+ concentration (from µM to 
mM) closes them [26]. In other words, cytosolic Ca2+ increase first exerts a positive feedback 
and facilitates SR channels opening whereas a further increase has an opposite effect and 
actually inhibits the SR channels opening [27-29]. Importantly enough to be mentioned, RyR 
phosphorylation by the second messenger cyclic ADP ribose (cADPR) and protein kinase A 
(PKA) enhances Ca2+ sensitivity, the phosphorylation induced by the protein kinase C (PKC) 
decreases RyR sensitivity to Ca2+ [29, 30]. The initial release occurs in the vicinity of the 
plasma membrane. It spreads into the cell through the regenerative release of Ca2+ by the 
RyR and /or the IP3R in the form of an intracellular Ca2+ wave travelling down the length of 
the cell [31-33]. When [Ca2+]i is integrated over an entire cell with time, these Ca2+ waves 
appear as rhythmical oscillations [34].  
Sarco/Endoplasmic Ca2+ATPases (SERCA), the only calcium transporters expressed within 
sarco/endoplasmic reticulum (SR), serve to actively return calcium into this organelle. In 
mammals, three SERCA genes ATP2A1, ATP2A2 and ATP2A3 coding for SERCA1, SERCA2 
and SERCA3 isoforms respectively have been identified [35]. Each gene gives rise to a 
different SERCA isoform through alternative splicing (Figure 2); they all have discrete tissue 
distributions and unique regulatory properties, providing a potential focal point within the 
cell for the integration of diverse stimuli to adjust and fine-tune calcium homeostasis in the 
SR/ER [36]. In VSMCs, SERCA2a and the ubiquitous SERCA2b isoforms are expressed; 
besides vascular smooth muscle, SERCA2a is preferentially expressed in cardiac and skeletal 
muscles. SERCA2b differs from SERCA2a by an extension of 46 amino acids that forms an 
                                                                 
5 RyR are structurally and functionally analogous to IP3R, although they are approximately twice as large and have 
twice the conductance of IP3R [27]; RyR channels are sensitive to store loading and IP3R channels are sensitized by the 
agonist-dependent formation of IP3. 
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additional trans-membrane domain setting the SERCA2b C terminus in the SR lumen [37]. 
Functional characterization of SERCA2 isoforms performed in transfected HEK-298 cells 
clearly indicated that the SERCA2a isoform displays a lower affinity for Ca2+ (K0.5 = 0.985 
µM) but has a higher turnover rate (ATP hydrolysis 70 s-1) compared to SERCA2b (K0.5 = 
0.508 µM; 35 s-1) [38]. Diversity of SERCA isoforms in the same cell suggests that each of 
them could be responsible for controlling unique cell functions.  
 
Figure 2. Alternative splicing of the human ATP2A2 genes, protein sizes of the SERCA2 isoforms. A. Repre-
sentation of the 3'-end of the human ATP2A2 gene. Broken lines with letters represent alternative splic-
ings. The position of stop codons for the corresponding isoforms and polyadenylation site are indicated 
by Sa-Sd & pA, respectively. B. Representation of the 3'-end of SERCA2a, SERCA2b, SERCA2c and 
SERCA2d mRNAs expressed in human cells and the sizes of the corresponding proteins. Wide boxes 
represent translated segments; the less wide boxes represent untranslated segments.  
SERCA2’s activity depends on its interaction with phospholamban and is inhibitory in its 
de-phosphorylated form. PKA phosphorylation of phospholamban results in its dissociation 
from SERCA2, thus activating the Ca2+ pumps [39]. Cyclic ADP-ribose was also reported to 
stimulate SERCA pump activity [40].  
As previously mentioned, SR Ca2+ content controls the sensitivity of SR Ca2+ channels, RyR 
and IP3R, as well as functioning of SOC-mediated Ca2+ entry, thereby determining the type 
of intracellular calcium transient. Since SOCs opening depends on Ca2+ content of the store, 
one may suggest that SERCA participates to its regulation. Consistent with this, SOCs open 
up when the leak of Ca2+ from intracellular stores is not compensated with SERCA activity; 
SERCA inhibitors such as thapsigargin which prevent Ca2+ uptake are commonly used to 
chemically induce SOC currents; several works have established that SERCA can cluster 
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2.3. Mechanisms of cytosolic Ca2+ oscillations in VSMC 
Ca2+ oscillations are one of the ways that VSMCs respond to agonists [43-47]. These Ca2+ 
oscillations are maintained during receptor occupancy and are driven by an endogenous 
pacemaker mechanism, called the cellular Ca2+ oscillator [12, 33, 34]. Ca2+ oscillators were 
classified into two main types, the membrane oscillators and the cytosolic oscillators [48]. 
Membrane oscillators are those which generate oscillations at the cell membrane by succes-
sive membrane depolarization. In most small resistance arteries, inhibitors of plasma mem-
brane voltage-dependent channels reduce or even abolish the membrane potential oscilla-
tions which precede rhythmical contractions. This suggests that rhythmic extracellular Ca2+ 
influx can be required for calcium oscillatory transient [34]. Besides, membrane oscillators 
greatly depend on Ca2+ entry in order to provide enough Ca2+ to charge up the intracellular 
stores for each oscillatory cycle. Some of the entry mechanisms characterized include the 
Na+/Ca2+ exchanger (NCX) operating in its reverse mode [32, 44, 49], the ATP-sensitive P2X 
receptor responsible for generating junctional Ca2+ transients (jCaTs) [50] or the L-type 
Cav1.2 channels operating as clusters in a “high open probability mode” to produce persis-
tent Ca2+ sparklets [51]. In the case of the latter, entry of Ca2+ through these L-type channel 
clusters does not directly activate RyR to produce sparks, but provides the necessary 
amount of Ca2+ to charge up the ER and sensitize the RyR [52]. Another way of internal store 
reloading is achieved by the various isoforms of the transient receptor potential (TRP) ion 
channel family, activated directly by DAG [5, 6].  
Cytosolic oscillators do not depend on the cell membrane to generate oscillations. Instead, 
they arise from intracellular store membrane instability. The pacemaker mechanism of 
cytosolic Ca2+ oscillator is based on the velocity of luminal Ca2+ loading and luminal Ca2+ 
content [53, 54]. The mechanism responsible for initiating Ca2+ release depends either on 
RyRs or IP3R activation. As soon as stores are sufficiently charged with Ca2+, the SR Ca2+ 
channels become sensitive to cytosolic Ca2+ and can participate to the process of Ca2+-
induced Ca2+-release, which is responsible for orchestrating the regenerative release of Ca2+ 
from the SR/ER. Importantly, extracellular Ca2+ influx is not required for cytosolic oscillator 
function. Indeed, the Ca2+ oscillations can be observed in the absence of extracellular Ca2+ 
[43, 45, 55, 56].  
Finally, it should be mentioned that SERCA proteins play a major role in the establish-
ment of oscillatory Ca2+ transient required for phasic contractile response6, independent-
ly from the type of oscillator. Indeed, the frequency of Ca2+ oscillations depends solely on 
the velocity with which Ca2+ is re-loaded to the SR. This allows the sensitization of SR 
release channels, which determine the timing of the next Ca2+ spike [54, 57]. Thus, as long 
as the IP3 membrane receptor/Ca2+ channel is activated, the next spike is initiated as soon 
as the sensitivity of IP3Rs (RyRs) is restored, resulting in oscillatory mode of calcium 
cycling. 
                                                                 
6Phasic contractions are apparent as rapid peaks, whereas tonic contractions cause gradual changes in force that can be 
maintained for prolonged periods. 
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3. Calcium cycling and signalling in vascular smooth muscle cells 
3.1. Vascular smooth muscle cell phenotype diversity 
VSMCs maintain a considerable plasticity throughout life, exhibiting a diverse range of 
phenotypes in response to local environmental changes [58, 59]. Because studies of smooth 
muscle phenotype have principally focused on mechanisms which control VSMC prolifera-
tion and differentiation [58], VSMC phenotypes are classified into two  
main categories: the synthetic/proliferating/migratory/inflammatory and the contrac-
tile/quiescent/differentiated phenotype. In mature vessels, most VSMCs exhibit a quies-
cent/contractile phenotype and control the vascular tone [58, 59]. Transition of contractile 
VSMCs towards a proliferating/migratory/inflammatory phenotype is one of the initial 
mechanisms leading to pathological vascular remodeling7 [58, 60]. Culturing VSMCs in vitro 
mimics this progression, as primary cultures rapidly lose differentiation markers and exhibit 
a synthetic phenotype [60]. 
Another possibility for classifying VSMCs is to categorize them based on their contractile 
properties which determine whether the smooth muscle is considered phasic or tonic. Phasic 
vascular smooth muscle refers to blood vessels displaying rhythmic contractile activity 
whereas tonic vascular smooth muscle refers to blood vessels displaying continuous con-
tractions [61]. Phasic contraction is the characteristic of small resistance arteries (SRA, 20-50 
µm diameters) which predominantly regulates vascular functions such as pressure and 
flow. In vivo small arteries exhibit a mixture of tonic and phasic contractions (RW: [34, 45, 62, 
63]) and/or conducted vasomotor response termed vasomotion8 [64].  
The contractile capacities of various VSMC phenotypes are determined by expression of 
different isoforms of contractile proteins. For instance, phasic contractions displayed by 
small arteries of the heart and lung, muscular femoral artery, small mesenteric arteries and 
renal afferent arteriole result from the VSMC expression of the fast isoform of smooth mus-
cle myosin heavy chain (MHC) which determines the velocity of shortening during vasomo-
tion (rev. [61]). Of note, lent isoform of smooth muscle myosin, so called “non muscular 
myosin, (NM-B)” is expressed in all types of VSMCs including synthetic/proliferating 
VSMC; it plays a significant role in force maintenance during tonic contraction [58, 61].  
Contractile response is initiated by the rise in cytosolic [Ca2+]i leading to the activation of 
Ca2+/calmodulin-dependent myosin light chain kinase (MLCK) [65]. However the mode of 
contraction, phasic or tonic, is determined by the type of cytosolic Ca2+ cycling. Different 
types of calcium cycling were observed in synthetic and contractile tonic or phasic VSMCs, 
in accordance with differential expression of calcium handling proteins [59, 60, 66].  
                                                                 
7Vascular remodeling was initially defined as the process of arterial enlargement to accommodate the plaque and 
maintain constant flow despite increases in atherosclerotic lesion mass. Experimental and clinical observations indicate 
that blood flow properties influence remodeling after angioplasty, hypertension, and flow diversion as well as 
atherosclerotic plaque progression [60]. 
8 Vasomotion or pulsative flow is suggested to enhance blood flow or tissue oxygenation (rev.[61])  
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3.2. Calcium cycling in synthetic/proliferating VSMC 
The hallmark of synthetic status of VSMCs is a lack of functional proteins entity associated with 
the contractile response [60]; we refer to voltage activated L-type calcium channels (LTCC), SR 
calcium release channel RyR and “fast” isoform of SR calcium pump SERCA2a (Figure 3). In 
line with this, large conductance K+ channels (BKCa), which are involved in negative feedback 
regulation of LTCC activity through plasma membrane hyperpolarization, are also down-
regulated in synthetic VSMC [67, 68]. On the other hand, the expression of the molecular enti-
ties modulating the plasma membrane Ca2+-release activated Ca2+ channel (CRAC) functioning 
[57, 69] are highly up-regulated; we refer to the proteins forming the CRAC complex or regulat-
ing the ICRAC (such as ORAI1-3 and STIM1) and to the IP3R [70, 71]. Besides, the expression of 
TRPCs family members, particularly TRPC1 and TRPC6, dramatically increases in synthetic 
cells leading to the increase of whole cell Ca2+ current [72, 73].  
In synthetic VSMC, agonist binding to PLC-coupled membrane receptors activates IP3R, 
resulting in a drastic increase of cytosolic Ca2+ which is weakly pumped by the “slow” calci-
um pump SERCA2b (the only isoform of SERCA expressed in synthetic VSMCs). The de-
pleted store triggers the translocation of STIM1 towards the plasma membrane, which, 
through the opening of CRAC, induces an extracellular Ca2+ influx. This translates into a 
long lasting increase of cytosolic calcium critical for the activation of Ca2+-sensitive transcrip-
tion factor NFAT (nuclear factor of activated T lymphocytes), required for proliferation and 
migration of VSMCs [56, 74]. Since these cells express contractile proteins, such as NM-B [58, 
61], one may suggest that long lasting increase of cytosolic calcium can also produces tonic 
contraction.  
Importantly enough to be mentioned, the restoration of SERCA2a expression by gene trans-
fer in synthetic VSMCs blocks their proliferation and migration via inhibition of transcrip-
tion factor NFAT [56, 75]. Molecular mechanisms of this effect are related to the prevention 
of functional association between STIM1 and Orai1 (CRAC protein entity) which lead to the 
suppression of store-operated calcium influx [56]. It is worth mentioning that SOC influx 
following agonist stimulation is not observed in contractile VSMCs, naturally expressing 
SERCA2a (Bobe & Lipskaia, unpublished data), highlighting again the importance of the 
SERCA isoform(s) expressed in VSMCs. 
3.3. Calcium cycling in contractile tonic and phasic VSMC 
In mature vessels, VSMCs mainly exhibit a tonic or phasic contractile phenotype. In contractile 
VSMCs extracellular calcium influx predominantly takes place through the voltage-dependent 
L-type calcium channel, LTCC9 (Figure 3). Extracellular Ca2+ influx causes a small increase of 
cytosolic Ca2+ generated by the opening of IP3R clusters, called puff and/or RyR2 clusters, 
called spark [28, 57]. These local rises of cytosolic Ca2+ generate a larger SR Ca2+ release through 
the Ca2+-induced Ca2+ release phenomenon. Elevation of free cytosolic calcium triggers VSMC 
contraction. The mode of intracellular calcium transient determines the type of contraction, 
                                                                 
9 In contractile VSMCs, NFAT can be activated by sustained Ca2+ influx (persistent Ca2+ sparklets) mediated by clusters 
of L-type Ca2+ channels operating in a high open probability mode [76, 77].  
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tonic or phasic. Steady state increase in cytosolic Ca2+ triggers tonic contraction; oscillatory 
type of Ca2+ transient triggers phasic contraction. [34, 76]. It is worth mentioning that accumu-
lating evidence indicate that SR Ca2+ATPase functioning/location within the cell (which greatly 
influences the velocity of calcium upload) determines the mode of Ca2+ transient in VSMCs. 
Consistent with this, i) “phasic” VSMCs display a greater number of peripherally located SR 
than “tonic” VSMCs; indeed “tonic” VSMCs exhibit centrally located SR; (rev in [61, 77]); ii) 
drugs which interfere with the IP3 pathway or intracellular stores abolish spontaneous vaso-
motion [11, 78]; iii) blocking SERCA strongly inhibits the Ca2+ oscillations, demonstrating that 
they are induced by SR Ca2+ release; this latter argument is further supported by the fact that 
oscillations are present even in the absence of extracellular Ca2+ [43, 45, 55, 56].  
 
Figure 3. Dynamic schematic representation of calcium cycling in contractile phasic or tonic and syn-
thetic VSMCs. Left panel: initiation of calcium event. Middle panel: resulting calcium transient and related 
physiological function. Right panel: termination of calcium event. The color intensity reflects Ca2+ concen-
trations.  Abbreviations: BK - potassium channel; DAG - diacylglycerol; IP3 - inositol-1,4,5-trisphosphate; 
IP3R - inositol-1,4,5-trisphosphate receptor; LTCC - voltage-gated L-Type Calcium channel; NCX - 
Na+/Ca2+ exchanger; NFAT - nuclear factor of activated T-lymphocytes; PLC - phospholipase C; PMCA – 
plasma membrane Ca2+ ATPase; ROC - receptor activated channel; RyR - ryanodine receptor; SERCA2a 
and SERCA2b - sarco(endo)plasmic reticulum Ca2+ ATPase type 2a and 2b; SOC - store operated Ca2+ 
channel; SR - sarcoplasmic reticulum, STIM1 - stromal interaction molecule 1.  
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The “fast” calcium pump SERCA2a, specifically expressed in contractile VSMCs can be 
responsible for the establishment of the “cytosolic oscillator”. Several arguments are in 
agreement with this proposal: i) SERCA2a has a higher catalytic turnover when compared to 
SERCA2b due to a higher rate of de-phosphorylation and a lower affinity for Ca2+; ii) SER-
CA2a is absent in synthetic VSMCs, which only exhibit tonic contraction, iii) transferring the 
SERCA2a gene to synthetic cultured VSMCs modifies the agonist-induced calcium transient 
from steady-state to oscillatory mode [56]. Therefore, one might suggest that the physiologi-
cal role of SERCA2a in VSMCs consists of controlling the “cytosolic oscillator”, thereby 
determining phasic vs tonic type of smooth muscle contraction.  
Despite the fact that agonist-induced Ca2+ oscillations are a characteristic feature of the acti-
vation mechanisms of VSMCs [43-47], oscillatory type of Ca2+ transient is poorly associated 
with phasic contractile response. In some vessels, asynchronous oscillations of individual 
VSMC maintain a particular vascular tonus. However, in small resistance vessels the oscilla-
tions of groups of cells are synchronized through gap-junctions resulting in the pulsative 
contractile response [34, 45, 79, 80]. This oscillatory activity can be regulated by variations of 
neurotransmitters following sympathetic activation and can affect contractile tone through 
the increase of frequency, thereby increasing blood flow or tissue oxygenation [43, 45, 46, 
81]. This frequency modulation could result from PKA phosphorylation of RyR, PLB and 
contractile proteins, as it has been established for cardiomyocytes [82-84]. Micro-vascular 
dysfunction, defined as the intrinsic changes in VSMCs contractility (such as reduction of 
frequency and shortening velocity of phasic contractions), observed in the context of cardio-
vascular [85, 86], may be related to reduced PKA phosphorylation of Ca2+ handling and 
contractile proteins, as observed in failing cardiomyocytes [82].  
4. SERCA2a as a potential target for treating vascular proliferative 
diseases 
Abundant proliferation of VSMCs is an important component of the chronic inflammatory 
response associated to atherosclerosis and related vascular occlusive diseases (intra-stent 
restenosis, transplant vasculopathy, and vessel bypass graft failure). Great efforts have been 
made to prevent/reduce trans-differentiation and proliferation of synthetic VSMCs. Anti-
proliferative therapies including the use of pharmacological agents and gene therapy ap-
proaches are, until now, considered as a suitable approach in the treatment of these disor-
ders [87]. Indeed, coronary stenting is the only procedure that has been proven to reduce the 
incidence of late restenosis after percutaneous transluminal coronary angioplasty ([88]). 
Nevertheless, post-interventional intra-stent restenosis, characterized by the re-narrowing of 
the arteries caused by VSMC proliferation, occurs in 10 to 20 % of patients. These disorders 
remain the major limitation of revascularization by percutaneous transluminal angioplasty 
and artery bypass surgery. The use of drug-eluting stents (stent eluting anti-proliferative 
drug) significantly reduces restenosis but impairs the re-endothelialization process and 
subsequently often induces late thrombosis [89, 90]. In human, trans-differentiation of con-
tractile VSMCs towards a synthetic/proliferating inflammatory/migratory phenotype after 
percutaneous transluminal angioplasty appears to be a fundamental process of vascular 
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proliferative disease [91]. In contrast, phenotypic re-differentiation of neo-intimal VSMCs 
after bare metal stent implantation was reported to be associated with a decline in platelet 
activation and inflammatory cell infiltration, and the regeneration of the endothelial cell 
layer [92]. Thus, defining novel molecular target(s) of DESs, that can simultaneously pre-
vents VSMC proliferation and adverse vascular remodeling while facilitating re-
endothelialization, is crucial. SERCA2a gene transfer prevents neo-intimal proliferation and 
intimal thickening in the rat carotid injury model by normalizing calcium cycling and inhib-
iting NFAT activity [75]. Furthermore, SERCA2a gene transfer prevents VSMC trans-
differentiation in injured segments while allowing re-endothelialization [75]. Thus, SER-
CA2a can be considered as a potential and powerful target for treating vascular proliferative 
disease.  
5. Concluding remarks 
Over the last decade, great progress has been made in the understanding of the various 
intracellular molecular mechanisms in VSMCs which control calcium cycling and excita-
tion/contraction or excitation/transcription coupling. VSMCs employ a great variety of Ca2+ 
signaling systems that are adapted to control their different contractile functions. Alterations 
in the expressions of Ca2+ handling molecules are closely associated with VSMC phenotype 
modulation. Furthermore, these changes in expression are inter-connected and each ac-
quired or lost Ca2+ signaling molecule represents a component of signaling module function-
ing as a single unit. 
In non-excitable synthetic VSMCs, calcium cycling results from the protein module 
ROC/IP3R/STIM1/ORAI1 which controls SOC influx. Agonist stimulation of synthetic 
VSMCs translates into a sustained increase in cytosolic Ca2+. This increase is required for the 
activation of NFAT downstream cellular signaling pathways inducing proliferation, migra-
tion and possibly an inflammatory response. Calcium cycling in excitable contractile VSMCs 
is governed by the protein module composed of ROC/LTCC/RyR2/SERCA2a and controls 
the contractile response. The location of particular ion channels within the smooth muscle 
cell with regards to internal stores, other membrane ion channels, gap junctions as well as 
the expression of fast isoforms of contractile proteins have a significant impact on the result-
ing phasic or tonic contractile response. Future studies unraveling the correlation between 
the dynamic changes in Ca2+ signaling protein expression and specific subcellular localiza-
tion are needed to delineate the mechanisms by which Ca2+ signaling molecules produce a 
phasic or tonic contractile response.  
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